It’s a tough time to be an early-stage medtech company in search of capital. Overall investment in the industry has remained strong across the U.S. and Europe but it is later-stage companies getting the financial commitments during a time of economic and regulatory uncertainty, according to a report from U.K.-based bank HSBC. Here are four takeaways from the report.
Read the full article: Medtech Funding Favoring Late-Stage Companies //
Source: https://www.modernhealthcare.com/medical-devices/mh-medtech-funding-2025-hsbc/